enGene Therapeutics Inc. (ENGN): 8-K filed Aug 11, 2026

Form type

8-K

Filing date

Aug 11, 2026

Accession number

0001193125-26-344559

Filer

enGene Therapeutics Inc. (CIK 1980845)